Latest Insider Transactions at Dexcom Inc (DXCM)
This section provides a real-time view of insider transactions for Dexcom Inc (DXCM). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of DEXCOM INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of DEXCOM INC's insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Sep 11
2023
|
Shelly Ramasamy Selvaraj SVP Chief Information Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
2,045
-4.05%
|
$214,725
$105.25 P/Share
|
Sep 01
2023
|
Matthew Vincent Dolan EVP, Strategy & Corporate Dev |
SELL
Open market or private sale
|
Direct |
56
-0.17%
|
$5,712
$102.32 P/Share
|
Aug 24
2023
|
Rimma Driscoll Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,008
+50.0%
|
-
|
Aug 23
2023
|
Steven Robert Pacelli EVP Managing Director Dexcom V |
SELL
Open market or private sale
|
Direct |
411
-0.33%
|
$43,977
$107.03 P/Share
|
Aug 22
2023
|
Jereme M Sylvain EVP, Chief Financal Officer |
SELL
Open market or private sale
|
Direct |
1,844
-2.47%
|
$191,776
$104.38 P/Share
|
Aug 11
2023
|
Karen M Dahut Director |
BUY
Bona fide gift
|
Indirect |
1,544
+11.19%
|
-
|
Aug 11
2023
|
Karen M Dahut Director |
SELL
Bona fide gift
|
Direct |
1,544
-34.7%
|
-
|
Aug 09
2023
|
Sadie Stern EVP, Chief HR Officer |
SELL
Open market or private sale
|
Direct |
392
-0.48%
|
$43,120
$110.71 P/Share
|
Jul 24
2023
|
Steven Robert Pacelli EVP Managing Director Dexcom V |
SELL
Open market or private sale
|
Direct |
412
-0.32%
|
$53,560
$130.58 P/Share
|
Jul 14
2023
|
Steven Robert Pacelli EVP Managing Director Dexcom V |
SELL
Open market or private sale
|
Direct |
5,031
-3.82%
|
$684,216
$136.0 P/Share
|
Jul 10
2023
|
Barry J. Regan EVP Operations |
SELL
Open market or private sale
|
Direct |
1,989
-2.91%
|
$254,592
$128.05 P/Share
|
Jul 10
2023
|
Sadie Stern EVP, Chief HR Officer |
SELL
Open market or private sale
|
Direct |
392
-0.48%
|
$50,176
$128.05 P/Share
|
Jun 23
2023
|
Steven Robert Pacelli EVP Managing Director Dexcom V |
SELL
Open market or private sale
|
Direct |
412
-0.31%
|
$51,500
$125.92 P/Share
|
Jun 15
2023
|
Shelly Ramasamy Selvaraj SVP Chief Information Officer |
SELL
Open market or private sale
|
Direct |
2,115
-4.03%
|
$274,950
$130.0 P/Share
|
Jun 09
2023
|
Sadie Stern EVP, Chief HR Officer |
SELL
Open market or private sale
|
Direct |
393
-0.47%
|
$47,553
$121.31 P/Share
|
May 23
2023
|
Steven Robert Pacelli EVP Managing Director Dexcom V |
SELL
Open market or private sale
|
Direct |
412
-0.31%
|
$48,616
$118.65 P/Share
|
May 22
2023
|
Jereme M Sylvain EVP, Chief Financal Officer |
SELL
Open market or private sale
|
Direct |
2,400
-3.11%
|
$280,800
$117.58 P/Share
|
May 18
2023
|
Nicholas Augustinos Director |
BUY
Bona fide gift
|
Indirect |
3,976
+9.47%
|
-
|
May 18
2023
|
Nicholas Augustinos Director |
SELL
Bona fide gift
|
Direct |
3,976
-56.65%
|
-
|
May 18
2023
|
Nicholas Augustinos Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,043
+30.24%
|
-
|
May 18
2023
|
Steven R Altman Director |
BUY
Bona fide gift
|
Indirect |
3,916
+5.88%
|
-
|
May 18
2023
|
Steven R Altman Director |
SELL
Bona fide gift
|
Direct |
3,916
-57.58%
|
-
|
May 18
2023
|
Steven R Altman Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,885
+29.79%
|
-
|
May 18
2023
|
Jay S Skyler Director |
BUY
Bona fide gift
|
Indirect |
3,876
+5.77%
|
-
|
May 18
2023
|
Jay S Skyler Director |
SELL
Bona fide gift
|
Direct |
3,876
-100.0%
|
-
|
May 18
2023
|
Karen M Dahut Director |
BUY
Bona fide gift
|
Indirect |
3,948
+26.92%
|
-
|
May 18
2023
|
Karen M Dahut Director |
SELL
Bona fide gift
|
Direct |
3,948
-47.01%
|
-
|
May 18
2023
|
Karen M Dahut Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,906
+25.71%
|
-
|
May 18
2023
|
Eric Topol Director |
BUY
Bona fide gift
|
Indirect |
3,952
+1.04%
|
-
|
May 18
2023
|
Eric Topol Director |
SELL
Bona fide gift
|
Direct |
3,952
-57.58%
|
-
|
May 18
2023
|
Eric Topol Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,911
+29.78%
|
-
|
May 18
2023
|
Kyle Malady Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,885
+15.67%
|
-
|
May 18
2023
|
Barbara Kahn Director |
BUY
Bona fide gift
|
Indirect |
3,976
+16.83%
|
-
|
May 18
2023
|
Barbara Kahn Director |
SELL
Bona fide gift
|
Direct |
3,976
-57.6%
|
-
|
May 18
2023
|
Barbara Kahn Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,927
+29.78%
|
-
|
May 18
2023
|
Bridgette P Heller Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,911
+10.69%
|
-
|
May 18
2023
|
Mark G Foletta Director |
BUY
Bona fide gift
|
Indirect |
4,488
+7.06%
|
-
|
May 18
2023
|
Mark G Foletta Director |
SELL
Bona fide gift
|
Direct |
4,488
-57.58%
|
-
|
May 18
2023
|
Mark G Foletta Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,306
+29.78%
|
-
|
May 18
2023
|
Richard Alexander Collins Director |
BUY
Bona fide gift
|
Indirect |
3,948
+9.78%
|
-
|
May 18
2023
|
Richard Alexander Collins Director |
SELL
Bona fide gift
|
Direct |
3,948
-57.6%
|
-
|
May 18
2023
|
Richard Alexander Collins Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,906
+29.77%
|
-
|
May 09
2023
|
Sadie Stern EVP, Chief HR Officer |
SELL
Open market or private sale
|
Direct |
393
-0.47%
|
$47,160
$120.19 P/Share
|
Apr 27
2023
|
Steven Robert Pacelli EVP Managing Director Dexcom V |
SELL
Open market or private sale
|
Direct |
5,031
-3.65%
|
$633,906
$126.0 P/Share
|
Apr 24
2023
|
Steven Robert Pacelli EVP Managing Director Dexcom V |
SELL
Open market or private sale
|
Direct |
412
-0.3%
|
$51,088
$124.68 P/Share
|
Apr 20
2023
|
Jacob Steven Leach EVP, Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
30,764
-10.59%
|
$3,845,500
$125.0 P/Share
|
Apr 20
2023
|
Shelly Ramasamy Selvaraj SVP Chief Information Officer |
SELL
Open market or private sale
|
Direct |
2,007
-3.68%
|
$250,875
$125.0 P/Share
|
Apr 20
2023
|
Barry J. Regan EVP Operations |
SELL
Open market or private sale
|
Direct |
2,214
-3.14%
|
$274,536
$124.5 P/Share
|
Apr 17
2023
|
Paul R Flynn EVP Global Revenue |
SELL
Open market or private sale
|
Direct |
2,781
-5.07%
|
$333,720
$120.0 P/Share
|
Apr 10
2023
|
Sadie Stern EVP, Chief HR Officer |
SELL
Open market or private sale
|
Direct |
393
-0.47%
|
$44,016
$112.35 P/Share
|